Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7351964, 8 pages
http://dx.doi.org/10.1155/2016/7351964
Review Article

Infection-Related Focal Segmental Glomerulosclerosis in Children

Department of Pediatric Nephrology, University Children’s Medical Clinic, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany

Received 25 December 2015; Revised 7 April 2016; Accepted 21 April 2016

Academic Editor: Sivagnanam Thamilselvan

Copyright © 2016 Anne Katrin Dettmar and Jun Oh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Jefferson and S. J. Shankland, “The pathogenesis of focal segmental glomerulosclerosis,” Advances in Chronic Kidney Disease, vol. 21, no. 5, pp. 408–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Vinai, P. Waber, and M. G. Seikaly, “Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review,” Pediatric Transplantation, vol. 14, no. 3, pp. 314–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Fogo, “Causes and pathogenesis of focal segmental glomerulosclerosis,” Nature Reviews Nephrology, vol. 11, no. 2, pp. 76–87, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Yu, M. Artomov, S. Brähler et al., “A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis,” The Journal of Clinical Investigation, vol. 126, no. 3, pp. 1067–1078, 2016. View at Publisher · View at Google Scholar
  5. P. Chandra and J. B. Kopp, “Viruses and collapsing glomerulopathy: a brief critical review,” Clinical Kidney Journal, vol. 6, no. 1, pp. 1–5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. S. H. Lai and K. N. Lai, “Viral nephropathy,” Nature Clinical Practice Nephrology, vol. 2, no. 5, pp. 254–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Glassock, “Immune complex-induced glomerular injury in viral diseases: an overview,” Kidney International, vol. 40, no. 35, pp. S5–S7, 1991. View at Google Scholar · View at Scopus
  8. W. G. Couser, “Mechanisms of glomerular injury in immune-complex disease,” Kidney International, vol. 28, no. 3, pp. 569–583, 1985. View at Publisher · View at Google Scholar · View at Scopus
  9. P. G. Conaldi, L. Biancone, A. Bottelli et al., “HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation,” The Journal of Clinical Investigation, vol. 102, no. 12, pp. 2041–2049, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Segerer, P. J. Nelson, and D. Schlöndorff, “Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 152–176, 2000. View at Google Scholar · View at Scopus
  11. J. Zhong, Y. Zuo, J. Ma et al., “Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy,” Kidney International, vol. 68, no. 3, pp. 1048–1060, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. E. Wenderfer, “Viral-associated glomerulopathies in children,” Pediatric Nephrology, vol. 30, no. 11, pp. 1929–1938, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. UNAIDS, World AIDS Day Report, 2011, http://www.unaids.org/sites/default/files/media_asset/JC2216_WorldAIDSday_report_2011_en_0.pdf, http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2011/20111121_FS_WAD2011_global_en.pdf.
  14. M.-L. Newell, H. Coovadia, M. Cortina-Borja, N. Rollins, P. Gaillard, and F. Dabis, “Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis,” The Lancet, vol. 364, no. 9441, pp. 1236–1243, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. P. L. Kimmel, T. M. Phillips, A. Ferreira-Centeno, T. Farkas-Szallasi, A. A. Abraham, and C. T. Garrett, “HIV-associated immune-mediated renal disease,” Kidney International, vol. 44, no. 6, pp. 1327–1340, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Shahinian, S. Rajaraman, M. Borucki, J. Grady, W. M. Hollander, and T. S. Ahuja, “Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients,” American Journal of Kidney Diseases, vol. 35, no. 5, pp. 884–888, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Daugas, J.-P. Rougier, and G. Hill, “HAART-related nephropathies in HIV-infected patients,” Kidney International, vol. 67, no. 2, pp. 393–403, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Ramsuran, R. Bhimma, P. K. Ramdial et al., “The spectrum of HIV-related nephropathy in children,” Pediatric Nephrology, vol. 27, no. 5, pp. 821–827, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. I. C. Anochie, F. U. Eke, and A. N. Okpere, “Human immunodeficiency virus-associated nephropathy (HIVAN) in Nigerian children,” Pediatric Nephrology, vol. 23, no. 1, pp. 117–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Genovese, D. J. Friedman, M. D. Ross et al., “Association of trypanolytic ApoL1 variants with kidney disease in African Americans,” Science, vol. 329, no. 5993, pp. 841–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Bhimma, M. U. Purswani, and U. Kala, “Kidney disease in children and adolescents with perinatal HIV-1 infection,” Journal of the International AIDS Society, vol. 16, Article ID 18596, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Husain, V. D. D'Agati, J. C. He, M. E. Klotman, and P. E. Klotman, “HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN,” AIDS, vol. 19, no. 17, pp. 1975–1980, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Gardenswartz, C. W. Lerner, G. R. Seligson et al., “Renal disease in patients with AIDS: a clinicopathologic study,” Clinical Nephrology, vol. 21, no. 4, pp. 197–204, 1984. View at Google Scholar · View at Scopus
  24. J. Soriano-Rosas, M. C. Avila-Casado, E. Carrera-Gonzalez, L. Chavez-Mercado, H. Cruz-Ortiz, and J. Rojo, “AIDS-associated nephropathy: 5-year retrospective morphologic analysis of 87 cases,” Pathology Research and Practice, vol. 194, no. 8, pp. 567–570, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Avila-Casado, T. I. Fortoul, and S. S. Chugh, “HIV-associated nephropathy: experimental models,” Contributions to Nephrology, vol. 169, pp. 270–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. L. A. Bruggeman, M. D. Ross, N. Tanji et al., “Renal epithelium is a previously unrecognized site of HIV-1 infection,” Journal of the American Society of Nephrology, vol. 11, no. 11, pp. 2079–2087, 2000. View at Google Scholar · View at Scopus
  27. J. Straus, C. Abitbol, G. Zilleruelo et al., “Renal disease in children with the acquired immunodeficiency syndrome,” The New England Journal of Medicine, vol. 321, no. 10, pp. 625–630, 1989. View at Publisher · View at Google Scholar · View at Scopus
  28. T. K. Chen, M. M. Estrella, and R. S. Parekh, “The evolving science of apolipoprotein-L1 and kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 25, no. 3, pp. 217–225, 2016. View at Publisher · View at Google Scholar
  29. S. Limou, P. D. Dummer, G. W. Nelson, J. B. Kopp, and C. A. Winkler, “APOL1 toxin, innate immunity, and kidney injury,” Kidney International, vol. 88, no. 1, pp. 28–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Lan, A. Jhaveri, K. Cheng et al., “APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability,” American Journal of Physiology—Renal Physiology, vol. 307, no. 3, pp. F326–F336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. D. J. Friedman and M. R. Pollak, “Apolipoprotein L1 and kidney disease in African Americans,” Trends in Endocrinology & Metabolism, vol. 27, no. 4, pp. 204–215, 2016. View at Publisher · View at Google Scholar
  32. B. T. Lee, V. Kumar, T. A. Williams et al., “The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival,” American Journal of Transplantation, vol. 12, no. 7, pp. 1924–1928, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Reeves-Daniel, J. A. DePalma, A. J. Bleyer et al., “The APOL1 gene and allograft survival after kidney transplantation,” American Journal of Transplantation, vol. 11, no. 5, pp. 1025–1030, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. P. E. Ray and C.-A. A. Hu, “Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children,” Future Virology, vol. 6, no. 7, pp. 883–894, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Lan, H. Wen, M. A. Saleem et al., “Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu,” Experimental and Molecular Pathology, vol. 98, no. 3, pp. 491–501, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. L. A. Bruggeman, Z. Wu, L. Luo et al., “APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease,” Journal of the American Society of Nephrology, 2016. View at Publisher · View at Google Scholar
  37. P. E. Ray, “Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy,” Pediatric Nephrology, vol. 24, no. 11, pp. 2109–2119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. I. McCulloch and P. E. Ray, “Kidney disease in HIV-positive children,” Seminars in Nephrology, vol. 28, no. 6, pp. 585–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. L. Kimmel, L. Barisoni, and J. B. Kopp, “Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations,” Annals of Internal Medicine, vol. 139, no. 3, pp. 214–226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. WHO, Antiretroviral therapy of HIV infection in infants and children: towards univesal access, 2006, http://www.who.int/hiv/pub/guidelines/art/en/print.html.
  41. L. A. Szczech, S. K. Gupta, R. Habash et al., “The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection,” Kidney International, vol. 66, no. 3, pp. 1145–1152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Ross and P. E. Klotman, “Recent progress in HIV-associated nephropathy,” Journal of the American Society of Nephrology, vol. 13, no. 12, pp. 2997–3004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. T. S. Ahuja, K. C. Abbott, L. Pack, and Y.-F. Kuo, “HIV-associated nephropathy and end-stage renal disease in children in the United States,” Pediatric Nephrology, vol. 19, no. 7, pp. 808–811, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. United States Department of Health and Human Services, Guide for HIV/AIDS Clinical Care, 2014, https://aidsinfo.nih.gov/guidelines/html/2/pediatric-treatment-guidelines/0.
  45. WHO, Guidance on Prevention of Viral Hepatitis B and C Among People Who Inject Drugs, 2012.
  46. B. J. McMahon, W. L. M. Alward, D. B. Hall et al., “Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state,” The Journal of Infectious Diseases, vol. 151, no. 4, pp. 599–603, 1985. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Y. Lin, “Clinical features and natural course of HBV-related glomerulopathy in children,” Kidney International Supplement, vol. 35, pp. S46–S53, 1991. View at Google Scholar
  48. K. Sakai, N. Morito, J. Usui et al., “Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection,” Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 371–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Khaira, B. K. Upadhyay, A. Sharma et al., “Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature,” Clinical and Experimental Nephrology, vol. 13, no. 4, pp. 373–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. O. Ozdamar, S. Gucer, and K. Tinaztepe, “Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children,” Pediatric Nephrology, vol. 18, no. 1, pp. 23–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. K. N. Lai, J. S. Tam, H. J. Lin, and F. M.-M. Lai, “The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia,” Nephron, vol. 54, no. 1, pp. 12–17, 1990. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Taskapan, O. Oymak, A. Dogukan, O. Ozbakir, and C. Utas, “Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form,” Clinical Nephrology, vol. 54, no. 2, pp. 161–163, 2000. View at Google Scholar · View at Scopus
  53. F. L. Connor, A. R. Rosenberg, S. E. Kennedy, and T. D. Bohane, “HBV associated nephrotic syndrome: resolution with oral lamivudine,” Archives of Disease in Childhood, vol. 88, no. 5, pp. 446–449, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. O. Sakallioglu, F. Gok, S. Kalman, A. E. Kurekci, O. Gunhan, and E. Gokcay, “Hepatitis B complicated focal segmental glomerulosclerosis,” Journal of Nephrology, vol. 18, no. 4, pp. 433–435, 2005. View at Google Scholar · View at Scopus
  55. C. Reinheimer, R. Allwinn, H. W. Doerr, and M. Wittek, “Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors,” Infection, vol. 38, no. 5, pp. 381–385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. K. J. Wierenga, J. R. Pattison, N. Brink et al., “Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease,” The Lancet, vol. 346, no. 8973, pp. 475–476, 1995. View at Google Scholar
  57. T. Y. H. Wong, P. K. S. Chan, C. B. Leung, C.-C. Szeto, J. S. Tam, and P. K. T. Li, “Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus,” American Journal of Kidney Diseases, vol. 34, no. 6, pp. 1132–1136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. W. C. Koch, J. H. Harger, B. Barnstein, and S. P. Adler, “Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy,” The Pediatric Infectious Disease Journal, vol. 17, no. 6, pp. 489–494, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Enders, A. Weidner, I. Zoellner, K. Searle, and G. Enders, “Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases,” Prenatal Diagnosis, vol. 24, no. 7, pp. 513–518, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Moudgil, C. C. Nast, A. Bagga et al., “Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy,” Kidney International, vol. 59, no. 6, pp. 2126–2133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Onguru, F. Dede, H. Bodur et al., “Glomerulonephritis associating parvovirus B19 infection,” Renal Failure, vol. 28, no. 1, pp. 85–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. S. M. Meehan, M. Pascual, W. W. Williams et al., “De novo collapsing glomerulopathy in renal allografts,” Transplantation, vol. 65, no. 9, pp. 1192–1197, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Ponticelli, G. Moroni, and R. J. Glassock, “De novo glomerular diseases after renal transplantation,” Clinical Journal of the American Society of Nephrology, vol. 9, no. 8, pp. 1479–1487, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Tanawattanacharoen, R. J. Falk, J. C. Jennette, and J. B. Kopp, “Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis,” American Journal of Kidney Diseases, vol. 35, no. 6, pp. 1166–1174, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Nakazawa, N. Tomosugi, K. Sakamoto et al., “Acute glomerulonephritis after human parvovirus B19 infection,” American Journal of Kidney Diseases, vol. 35, article E31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Barisoni, W. Kriz, P. Mundel, and V. D'Agati, “The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy,” Journal of the American Society of Nephrology, vol. 10, no. 1, pp. 51–61, 1999. View at Google Scholar · View at Scopus
  67. K. E. Brown, S. M. Anderson, and N. S. Young, “Erythrocyte P antigen: cellular receptor for B19 parvovirus,” Science, vol. 262, no. 5130, pp. 114–117, 1993. View at Publisher · View at Google Scholar · View at Scopus
  68. L. L. W. Cooling, T. A. W. Koerner, and S. J. Naides, “Multiple glycosphingolipids determine the tissue tropism of parvovirus B19,” Journal of Infectious Diseases, vol. 172, no. 5, pp. 1198–1205, 1995. View at Publisher · View at Google Scholar · View at Scopus
  69. A. K. Dettmar, E. Binder, F. R. Greiner et al., “Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component,” Infection and Immunity, vol. 82, no. 5, pp. 1872–1879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. A. P. Sanchez and D. M. Ward, “Therapeutic apheresis for renal disorders,” Seminars in Dialysis, vol. 25, no. 2, pp. 119–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Albaqumi, T. J. Soos, L. Barisoni, and P. J. Nelson, “Collapsing glomerulopathy,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2854–2863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Kaito, K. Kamei, E. Kikuchi et al., “Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin,” Pediatric Nephrology, vol. 25, no. 5, pp. 957–959, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. J. K. Tucker, “Focal segmental glomerulosclerosis in African Americans,” The American Journal of the Medical Sciences, vol. 323, no. 2, pp. 90–93, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. G. Crenshaw, S. Bigler, M. Salem, and E. D. Crook, “Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors,” The American Journal of the Medical Sciences, vol. 319, no. 5, pp. 320–325, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. S. A. S. Staras, W. D. Flanders, S. C. Dollard, R. F. Pass, J. E. McGowan Jr., and M. J. Cannon, “Cytomegalovirus seroprevalence and childhood sources of infection: a population-based study among pre-adolescents in the United States,” Journal of Clinical Virology, vol. 43, no. 3, pp. 266–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. S. L. Bate, S. C. Dollard, and M. J. Cannon, “Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004,” Clinical Infectious Diseases, vol. 50, no. 11, pp. 1439–1447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. Z. W. Naing, G. M. Scott, A. Shand et al., “Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention,” The Australian & New Zealand Journal of Obstetrics & Gynaecology, vol. 56, no. 1, pp. 9–18, 2016. View at Publisher · View at Google Scholar
  78. A. L. Distéfano, A. Alonso, F. Martin, and F. Pardon, “Human cytomegalovirus: detection of congenital and perinatal infection in Argentina,” BMC Pediatrics, vol. 4, article 11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. S. B. Boppana, S. A. Ross, and K. B. Fowler, “Congenital cytomegalovirus infection: clinical outcome,” Clinical Infectious Diseases, vol. 57, pp. S178–S181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Bromfield, R. McQuillan, R. John, and C. Avila-Casado, “The significance of tubuloreticular inclusions as a marker of systemic stimulation by interferons in a case of focal and segmental glomerulosclerosis associated with cytomegalovirus (CMV) infection,” Clinical Kidney Journal, vol. 7, no. 2, pp. 174–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. C. La Rosa and D. J. Diamond, “The immune response to human CMV,” Future Virology, vol. 7, no. 3, pp. 279–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. C. Presne, C. Cordonnier, R. Makdassi, A. Pruna, and A. Fournier, “Collapsing glomerulopathy and cytomegalovirus, what are the links?” Presse Medicale, vol. 29, no. 33, pp. 1815–1817, 2000. View at Google Scholar · View at Scopus
  83. L. Tomlinson, Y. Boriskin, I. McPhee, S. Holwill, and P. Rice, “Acute cytomegalovirus infection complicated by collapsing glomerulopathy,” Nephrology Dialysis Transplantation, vol. 18, no. 1, pp. 187–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. H. F. Wechsler, A. H. Rosenblum, and C. T. Sills, “Infectious mononucleosis; report of an epidemic in an Army post,” Annals of Internal Medicine, vol. 25, p. 113, 1946. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Lee and C. M. Kjellstrand, “Renal disease in infectious mononucleosis,” Clinical Nephrology, vol. 9, no. 6, pp. 236–240, 1978. View at Google Scholar · View at Scopus
  86. J. L. Becker, F. Miller, G. J. Nuovo, C. Josepovitz, W. H. Schubach, and E. P. Nord, “Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis,” The Journal of Clinical Investigation, vol. 104, no. 12, pp. 1673–1681, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. J. M. Frazao, L. Elangovan, A. J. Felsenfeld, T. M. Stanley, and A. H. Cohen, “Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure,” Nephrology, Dialysis, Transplantation, vol. 13, pp. 1849–1852, 1998. View at Publisher · View at Google Scholar
  88. M. Kunimoto, Y. Hayashi, K. Kuki et al., “Analysis of viral infection in patients with iga nephropathy,” Acta Oto-Laryngologica, vol. 113, supplement 508, pp. 11–18, 1993. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Ranganath, A. R. Pandey, and M. Pavan, “Crescentic glomerulonephritis and leucocytoclastic vasculitis associated with acute EBV infection,” Nephrology, vol. 16, no. 6, p. 617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. C. E. Araya, R. P. González-Peralta, S. Skoda-Smith, and V. R. Dharnidharka, “Systemic Epstein-Barr virus infection associated with membranous nephropathy in children,” Clinical Nephrology, vol. 65, no. 3, pp. 160–164, 2006. View at Google Scholar · View at Scopus
  91. A. Joshi, A. Arora, D. Cimbaluk, G. Dunea, and P. Hart, “Acute Epstein-Barr virus infection-associated collapsing glomerulopathy,” Clinical Kidney Journal, vol. 5, no. 4, pp. 320–322, 2012. View at Publisher · View at Google Scholar · View at Scopus